A. Norman

3.1k total citations · 1 hit paper
42 papers, 2.3k citations indexed

About

A. Norman is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Norman has authored 42 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 16 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Norman's work include Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal Cancer Surgical Treatments (6 papers). A. Norman is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal Cancer Surgical Treatments (6 papers). A. Norman collaborates with scholars based in United Kingdom, Germany and United States. A. Norman's co-authors include David Cunningham, Jervoise Andreyev, J. Oates, Paul J. Ross, David P. Dearnaley, A. Horwich, J. Nicholls, Biren Parikh, Mark Hill and Răzvan Popescu and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and The Journal of Urology.

In The Last Decade

A. Norman

41 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

1998 603 citations Jervoise Andreyev, A. Norman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Norman United Kingdom	19	1.0k	873	808	491	270	42	2.3k
Jean‐Emmanuel Kurtz France	28	891 0.9×	364 0.4×	1.1k 1.4×	243 0.5×	420 1.6×	113	2.6k
Emmanuel Mitry France	21	1.5k 1.5×	459 0.5×	600 0.7×	231 0.5×	138 0.5×	70	2.1k
David Yü Greenblatt United States	27	1.1k 1.0×	1.0k 1.2×	423 0.5×	125 0.3×	578 2.1×	51	2.6k
J. Oates United Kingdom	14	2.1k 2.1×	1.7k 1.9×	1.9k 2.4×	429 0.9×	299 1.1×	25	3.6k
Henrik Harling Denmark	33	2.5k 2.4×	2.2k 2.6×	618 0.8×	123 0.3×	234 0.9×	104	3.6k
Reza Asari Austria	23	417 0.4×	1.1k 1.2×	311 0.4×	302 0.6×	152 0.6×	69	1.7k
Insoo Suh United States	27	388 0.4×	1.5k 1.7×	396 0.5×	123 0.3×	232 0.9×	108	2.5k
Inkeun Park South Korea	25	665 0.7×	464 0.5×	870 1.1×	341 0.7×	460 1.7×	107	1.7k
Kazunari Sasaki United States	31	1.3k 1.3×	1.5k 1.7×	552 0.7×	278 0.6×	193 0.7×	211	3.3k
Norio Yukawa Japan	24	939 0.9×	1.1k 1.3×	1.3k 1.6×	413 0.8×	233 0.9×	299	2.6k

Countries citing papers authored by A. Norman

Since Specialization

Citations

This map shows the geographic impact of A. Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Norman more than expected).

Fields of papers citing papers by A. Norman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Norman. The network helps show where A. Norman may publish in the future.

Co-authorship network of co-authors of A. Norman

This figure shows the co-authorship network connecting the top 25 collaborators of A. Norman. A scholar is included among the top collaborators of A. Norman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Norman. A. Norman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hawkins, M., et al.. (2009). The effect of treatment position, prone or supine, on dose–volume histograms for pelvic radiotherapy in patients with rectal cancer. British Journal of Radiology. 82(976). 321–327. 27 indexed citations

Formica, Vincenzo, A. Norman, David Cunningham, et al.. (2009). Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in Assessing Prognosis and Predicting First-Line Treatment Efficacy in Follicular Lymphoma Patients. Acta Haematologica. 122(4). 193–199. 13 indexed citations

Khalid, Usman, A. Norman, & Jervoise Andreyev. (2007). Elevated C-reactive protein levels are not a feature of uncomplicated radiation-induced bowel injury. European Journal of Cancer Care. 16(4). 346–350. 9 indexed citations

Chau, Ian, David Cunningham, Christopher Russell, et al.. (2006). Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials. British Journal of Cancer. 94(8). 1107–1115. 62 indexed citations

Sweetman, Joseph, Maggie Watson, A. Norman, et al.. (2006). Feasibility of familial PSA screening: psychosocial issues and screening adherence. British Journal of Cancer. 94(4). 507–512. 16 indexed citations

Chong, Geoff, David Cunningham, A. Norman, et al.. (2005). Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan. British Journal of Cancer. 93(5). 510–514. 55 indexed citations

Waters, Justin S., David Cunningham, Ian Chau, et al.. (2005). Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma. British Journal of Cancer. 92(8). 1352–1357. 42 indexed citations

Bowen, Joanne M., K. Newbold, Peter Blake, et al.. (2005). Do Serum Levels of Eosinophil Granule-derived Protein Change in Patients Undergoing Pelvic Radiotherapy?. Clinical Oncology. 17(5). 382–384. 5 indexed citations

Parker, Chris, et al.. (2005). The utility of digital rectal examination after radical radiotherapy for prostate cancer. Clinical Oncology. 17(3). 172–173. 10 indexed citations

10.

Angèle, Sandra, Alison Falconer, S M Edwards, et al.. (2004). ATM polymorphisms as risk factors for prostate cancer development. British Journal of Cancer. 91(4). 783–787. 75 indexed citations

11.

Assersohn, L., Gina Brown, David Cunningham, et al.. (2003). Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma. Annals of Oncology. 15(1). 64–69. 110 indexed citations

12.

Kelleher, Muireann, Niall C. Tebbutt, David Cunningham, et al.. (2003). Mitomycin C, Carboplatin and Protracted Venous Infusion 5-Fluorouracil in Advanced Oesophago–gastric and Pancreatic Cancer: Results of Two Phase II Studies. Clinical Oncology. 15(3). 92–97. 2 indexed citations

13.

Norman, A., et al.. (2003). Development of a disease specific questionnaire to supplement a generic tool for QoL in colorectal cancer. Psycho-Oncology. 12(7). 675–685. 13 indexed citations

14.

Waters, Justin S., Diana Tait, David Cunningham, et al.. (2002). A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagus. Annals of Oncology. 13(11). 1763–1770. 9 indexed citations

15.

Patterson, Helen, A. Norman, Swarupa Mitra, et al.. (2001). Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone. Radiotherapy and Oncology. 59(1). 5–11. 57 indexed citations

16.

Shahidi, Maryam, A. Norman, James Gadd, et al.. (2001). Recovery of Serum Testosterone, LH and FSH Levels Following Neoadjuvant Hormone Cytoreduction and Radical Radiotherapy in Localized Prostate Cancer. Clinical Oncology. 13(4). 291–295. 29 indexed citations

17.

Chau, Ian, Andrew Webb, David Cunningham, et al.. (2001). Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer. British Journal of Cancer. 85(9). 1258–1264. 20 indexed citations

18.

Crawley, Charles, Paul J. Ross, A. Norman, A Hill, & David Cunningham. (1998). The Royal Marsden experience of small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. British Journal of Cancer. 78(4). 508–510. 55 indexed citations

19.

Lampe, Hans, A. Horwich, A. Norman, J. Nicholls, & David P. Dearnaley. (1997). Fertility after chemotherapy for testicular germ cell cancers.. Journal of Clinical Oncology. 15(1). 239–245. 201 indexed citations

20.

Ross, Paul J., Andrew Webb, David Cunningham, et al.. (1997). Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience. Annals of Oncology. 8(2). 111–115. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact